Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,072 public trials 579 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

NCT05602363

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • UC Irvine Health Orange, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

NCT06049290

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Shougang Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 26 locations
View Trial Details
Recruiting

European Myeloma Network (EMN) Sample Project

NCT06237803

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Myeloma, +20 more
Locations
  • Alfred Hospital Melbourne, Australia
  • KUK Linz Linz, Austria
  • Medical University Vienna Vienna, Austria
  • Department of Haematology UZ Leuven Gasthuisberg Leuven, Belgium
View all 41 locations
View Trial Details
Recruiting

Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma

NCT06645678

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • National University Hospital (NUH) Singapore
  • Singhealth Duke NUS blood cancer center Singapore
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea
View Trial Details

Related conditions